A 55-year-old with hypertension and hyperlipidaemia presents for routine review. He is concerned about his cardiovascular risk. According to NICE guidelines, which drug class is recommended first-line for primary prevention of cardiovascular events in individuals with elevated QRISK3 over 10%?